However, during sustained activation of NMDA and AMPA receptors such as during cerebral ischemia, GABABR1 and R2 are phosphorylated and targeted for lysosomal degradation resulting in decreased GABABR receptor expression at the plasma membrane [41]. The gene discussed is GABBR1; the disease is brain ischemia.